Viewing Study NCT02981095


Ignite Creation Date: 2025-12-17 @ 2:47 PM
Ignite Modification Date: 2025-12-23 @ 4:52 PM
Study NCT ID: NCT02981095
Status: COMPLETED
Last Update Posted: 2016-12-02
First Post: 2016-11-25
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Effect of Bupivacaine Application on Postthyroidectomy Pain
Sponsor: Istanbul University
Organization:

Study Overview

Official Title: Bupivacaine Application Reduces Postthyroidectomy Pain: Cerrahpaşa Experience
Status: COMPLETED
Status Verified Date: 2016-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Investigators aimed to evaluate the impact of bupivacaine administration into the surgical field after total thyroidectomy on post-operative pain and analgesic requirement with a double-blind, prospective, clinical, randomized study.

Pain assessment was performed with the visual analog score (VAS). Participants were pre-operatively, divided into two groups randomly to receive either bupivacaine or not. One group received a 10 ml of bupivacaine solution while the other group was treated with the same volume of 0.9% sodium chloride (NaCl) through the drain after completion of total thyroidectomy procedure. All participants were anesthetized and operated with the same anesthesia and surgical team.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: